ãã€ãªå»è¬åäŒæ¥ã§ãã Syros Pharmaceuticals, Inc. ã¯ãããããã³åäžéºäŒåçŸæ£ã®æ²»çè¬ã®éçºãšãéºäŒåå¶åŸ¡è¬ã®ãã€ãã©ã€ã³ã®æ§ç¯ã«éç¹ã眮ããŠããŸããå瀟ã®äž»å補ååè£ã¯ãéžæçã¬ããã€ã³é
žå容äœã¢ã«ãã¡äœåè¬ SY-1425 (æ¥æ§éªšé«æ§çœè¡ç
ã®ã²ãã å®çŸ©ãããæ£è
ãµãã»ããã察象ã«ç¬¬ II çžèšåºè©Šéšã骚é«ç°åœ¢æçå矀æ£è
ã察象ã«ç¬¬ III çžèšåºè©Šéšã宿œäž)ããµã€ã¯ãªã³äŸåæ§ãããŒãŒ 7 é»å®³å€ SY-5609 (ç¹å®ã®é²è¡æ§åºåœ¢è
«çã®æ£è
ã察象ã«ç¬¬ I çžèšåºè©Šéšã宿œäž)ãããã³æ¥æ§å骚é«çæ§çœè¡ç
ã®æ£è
ãæ²»çããããã®æ°ããçµå£äžé
žåãçŽ SY-2101 ã§ããå瀟ã¯ã骚é«å¢æ®æ§è
«çã«éç¹ã眮ããæ²»çæšçãç¹å®ãããããIncyte Corporation ãšæšççºèŠãç ç©¶ååãããã³ãªãã·ã§ã³å¥çŽãç· çµããŠããŸãããŸããTMRC Co. Ltd. ãšã¿ããããã³ã®éçºããã³åååã«é¢ããã©ã€ã»ã³ã¹å¥çŽãç· çµããŸãããå瀟ã¯ä»¥å㯠LS22, Inc. ãšããŠç¥ãããŠããŸãããã2012 幎 8 æã« Syros Pharmaceuticals, Inc. ã«ç€Ÿåã倿ŽããŸãããSyros Pharmaceuticals, Inc. 㯠2011 幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã±ã³ããªããžã«æ¬ç€Ÿã眮ããŠããŸãã